INVICTA DIAGNOSTIC...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO INVICTA DIAGNOSTIC...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
ID

Invicta Diagnostic Ltd

NSE SME · SME IPO
Listed NSE SME SME Live Chart
Issue Price
₹85
₹85
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹85
Based on GMP
Min. Investment
₹136,000
1 lot × 1600 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
01 Dec 2025
Close Date
03 Dec 2025
Allotment
04 Dec 2025
Listing Date
08 Dec 2025
Exchange
NSE SME
Price Band
₹85
Listing Price
See chart
Allotment Status
Price Band
₹85
Per share
Face Value
₹10 per share
 
Lot Size
1,600 Shares
per lot
Issue Size
33,08,800 shares (aggregating up to ₹28.12 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹136,000
1 lot
Pre-IPO Holding
92,63,173 shares
Promoters
Post-IPO Holding
1,25,71,973 shares
Promoters
P/E (Pre)
14.51x
 
P/E (Post)
13.08x
 
EPS (Pre)
₹5.86
 
EPS (Post)
₹6.50
 
UPI Deadline
2025-12-03
Mandate
Anchor AllotmentSun, 30 Nov 2025
Basis of AllotmentThu, 04 Dec 2025
Refund InitiationFri, 05 Dec 2025
Demat CreditFri, 05 Dec 2025
Listing DayMon, 08 Dec 2025
UPI Mandate Deadline2025-12-03
Sale TypeFresh Capital
Net Offer to Public31,42,400 shares (aggregating up to ₹26.71 Cr)
Market Maker Quota1,66,400 shares (aggregating up to ₹1.41 Cr)
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Invicta Diagnostic Ltd IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 03 Dec 2025.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
Market Maker
Awaited
166,400
₹1.41
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
3,308,800
100% ₹28.12
IPO Shares Offered
Invicta Diagnostic Ltd IPO total issue size: ₹28.12 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Market Maker 166,400 ₹1.41
5.03%
Total 3,308,800 ₹28.12
100.00%
* Based on upper price band ₹85 per share
Lot Size & Investment
Lot Size
1,600
Shares per Lot
Issue Price
₹85.00
Upper Band
Min Investment
₹136,000
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)23,200₹272,000
Retail (Max — 13 Lots)1320,800₹1,768,000
S-HNI (Min — 14 Lots)1422,400₹1,904,000
B-HNI (Min — 68 Lots)68108,800₹9,248,000
* Issue Price ₹85 × Lot Size 1,600 shares
IPO Schedule
Anchor
30 Nov 2025
✓ Done
IPO Open
01 Dec 2025
✓ Done
IPO Close
03 Dec 2025
✓ Done
Allotment
04 Dec 2025
✓ Done
Refunds
05 Dec 2025
✓ Done
Demat Credit
05 Dec 2025
✓ Done
Listing Day
08 Dec 2025
✓ Done
Invicta Diagnostic Ltd — Live Price LIVE
₹85.00
INR · NSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹85.00 Live Price
About Invicta Diagnostic Ltd
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand 'PC Diagnostics' through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra.Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:A flagship hub in Thane West offering full-spectrum pathology and advanced radiology (PET CT, MRI)Three additional hubs (Bhayandar, Byculla, Marol) providing specialised diagnostic servicesThree spokes in Lower Parel, Sewri, and Kalwa focused on basic imaging (X-ray, ultrasound) and sample collection.The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.Invicta Diagnostics provides a comprehensive suite of diagnostic services, which includes:Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panelsSpecialised Tests: Covers molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panelsSample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres.As of October 31, 2025, the company employed 157 permanent employees.Competitive Strength:Expanding presence in the Mumbai Metropolitan Region (“MMR”), specifically in the radiology sector;A diagnostics provider that offers a one-stop solution at an affordable price.Technical capability and technology with IT infrastructure;Dedicated management team with significant industry experience; andImplementation of the Hub and Spoke Model.
Objects of the Issue
1
Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra; and
2
General Corporate purposes
Invicta Diagnostic Ltd Financials (Amount in ₹ Crore)
Revenue from Operations
₹15.9
31 Mar 2024
₹30.2
31 Mar 2025
₹17.1
30 Sep 2025
Profit After Tax (PAT)
₹3.8
31 Mar 2024
₹4.9
31 Mar 2025
₹4.1
30 Sep 2025
Particulars30 Sep 202531 Mar 202531 Mar 2024
Revenue from Operations 17.08 30.18 15.90
EBITDA 6.77 9.20 7.09
Profit After Tax (PAT) 4.08 4.93 3.81
Net Worth 23.68 13.60 8.67
Total Assets 34.90 21.22 15.89
Reserves & Surplus 14.42 5.18 8.54
Borrowings 3.72 3.54 3.81
EBITDA Margin (%) 30.57%
PAT Margin (%) 16.38%
P/BV Ratio
5.26
RoE
44.28%
RoCE
42.00%
RoNW
36.25%
PAT Margin
16.38%
EBITDA Margin
30.57%
Debt/Equity
0.26
Issue Structure & Shareholding
Total Shares Offered33,08,800 (100.00%)
Net Offer to Public31,42,400 shares (aggregating up to ₹26.71 Cr)
Reserved for Market Maker1,66,400 shares (aggregating up to ₹1.41 Cr)
Pre-Issue Promoter Holding92,63,173 shares
Post-Issue Promoter Holding1,25,71,973 shares
P/BV Ratio5.26
RoE44.28%
RoCE42.00%
Debt / Equity0.26
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
Socradamus Capital Pvt.Ltd
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Invicta Diagnostic Ltd IPO subscribed?

Invicta Diagnostic Ltd IPO is subscribed 1.00 times by Dec 03, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Invicta Diagnostic Ltd IPO retail subscription status?

The Invicta Diagnostic Ltd IPO retail category is subscribed 1.00 times as of 03 Dec 2025. The retail portion is oversubscribed.

How to subscribe Invicta Diagnostic Ltd IPO?

Subscribe via your broker app using ASBA or UPI. Opens 01 Dec 2025 and closes 03 Dec 2025. Min investment: ₹136,000 (1 lot = 1,600 shares). UPI mandate: 2025-12-03.

How many times Invicta Diagnostic Ltd IPO subscribed?

The Invicta Diagnostic Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Invicta Diagnostic Ltd IPO allotment?

Check allotment on the registrar website (Bigshare Services Pvt.Ltd) at https://ipo.bigshareonline.com/IPO_Status.html. Enter your PAN, application number or DP/Client ID. Allotment date: 04 Dec 2025. Refunds: on 05 Dec 2025.

When Invicta Diagnostic Ltd IPO will be listed?

The Invicta Diagnostic Ltd IPO listing date is 08 Dec 2025, Monday. Listed on: NSE SME. Issue price: ₹85. Estimated listing: ₹85. GMP: NIL.

When Invicta Diagnostic Ltd IPO close?

The Invicta Diagnostic Ltd IPO closes on 03 Dec 2025, Wednesday. UPI mandate: 2025-12-03. Allotment: 04 Dec 2025. Listing: 08 Dec 2025.